Bloomberg News cites Public Citizen on Remdesivir Cost

By Christin Flanagan

“A $1 per day pricing for the treatment rung true for one consumer group, Public Citizen, which claimed that should be enough to cover the manufacturing costs and ‘a reasonable profit’ to the Foster City, California-based Gilead.”

Read the full story here.